drugset / Trial / NCT07270432
Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the safety and efficacy of DNN.65.21.005 versus Combodart® in the treatment of benign prostatic hyperplasia
Timeline
- Start
- 2026-01
- Primary completion
- 2027-04
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Combodart® | Unknown | — | — |
| Subject | DNN.65.21.005 | Unknown | — | — |